patient care

6:41
Supportive care and prophylaxis of the side effects of myeloma drugs
Heinz Ludwig
2:09
May the EuroCAR-T Force be with you: improving CAR-T patient care
Victoria Metaxa
2:04
Emerging therapies in AML: why patients should be optimistic
Naval Daver
3:08
CAR T-cell therapy: the patient’s perspective
Bregje Verhoeven
4:03
Communication between CLL patients and doctors
Ben Kennedy
3:42
Transitional care priorities for teenagers/young adults with SCD and chronic diseases
Subarna Chakravorty
1:03
Multiple myeloma: what needs to change to improve care?
Tanya Burton
2:18
Self-administration of bortezomib in multiple myeloma: results from Cardiff
Tanya Burton
1:27
Update on CLL research at Memorial Sloan Kettering
Anthony Mato
0:57
The role of the nurse in ensuring QoL in CAR T-cell patients
Lissa Gray
3:06
Personalizing survivorship care
Navneet Majhail
1:12
The EBMT Nurses Group and the patient advocacy track
John Murray
1:14
The evolution of patient advocacy
Jan Geissler
1:28
The importance of patient advocacy tracks at congresses
Jan Geissler
0:53
The aims of the Patvocates Network
Jan Geissler
1:08
Current challenges in myeloma therapy
Karthik Ramasamy
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJHemOnc is intended for healthcare professionals